betabionics.comHealthcareFounded: 2015Funding to Date: $132MM
Beta Bionics is the developer of iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.
View Enterprise Value for Beta Bionics.